Skip to content
Home » Leadership in the Age of AI – Paul Hudson and Lindsay Levin (Transcript)

Leadership in the Age of AI – Paul Hudson and Lindsay Levin (Transcript)

Here is the full transcript of a conversation between TED’s Lindsay Levin and Paul Hudson at TED conference.

In a thought-provoking conversation between TED’s Lindsay Levin and Paul Hudson, CEO of Sanofi, the duo explored the transformative impact of Artificial Intelligence (AI) on the business landscape, particularly in the pharmaceutical industry. Hudson emphasized Sanofi’s commitment to leading the pharmaceutical sector by leveraging AI at scale, highlighting the company’s aggressive approach towards integrating AI into daily operations to enhance decision-making and efficiency.

He candidly discussed the challenges of data transparency and the initial resistance within organizations to embrace AI fully. Hudson also addressed the broader implications of AI adoption on the workforce, suggesting that AI’s role is not about job displacement but rather about creating more meaningful work and driving innovation. The dialogue touched upon the importance of leadership in navigating the complexities of AI integration, with Hudson pointing out the shift towards younger talent driving change and offering fresh perspectives on AI applications.

The conversation also delved into sustainability and healthcare, underscoring the need for collaborative efforts to tackle global challenges. Overall, Hudson’s insights painted a picture of an era where AI acts as a catalyst for significant industrial transformation, urging leaders and organizations to embrace change boldly.

Listen to the audio version here:


The Era of AI and Its Impact on Business

LINDSAY LEVIN: So, we’re living in an era with multiple overlapping disruptions that business is facing, and I want to dive straight in and talk about one of the biggest of those, which is AI. How are you approaching AI?

PAUL HUDSON: You know, AI at scale, it’s a whole big subject, of course, but for us, at Sanofi, we aim to be the world’s leading pharmaceutical company using AI at scale. Why and how are we going to do that? It’s pretty straightforward. We have 23,000 people using AI as often as every month, 9,000 people in the company using AI as often as every day. We’re boldly taking on the opportunity to completely disrupt the business. We don’t have a choice. It’s the fourth industrial revolution. It’s here whether we like it or not.

Pages: First |1 | ... | Next → | Last | View Full Transcript